Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats
- PMID: 11746193
- DOI: 10.1002/jat.782
Potential protective role of angiotensin-converting enzyme inhibitors captopril and enalapril against adriamycin-induced acute cardiac and hepatic toxicity in rats
Abstract
Captopril and enalapril-angiotensin-converting enzyme (ACE) inhibitors-were evaluated for their antioxidative protective action against adriamycin-induced cardiac and hepatic toxicity. Rats were treated with either captopril (10 mg kg(-1)) or enalapril (2 mg kg(-1)) intragastrically (i.g.) daily for 7 days before single intraperitoneal (i.p.) injection with adriamycin (15 mg kg(-1)). The animals were killed 30 h after adriamycin administration. Adriamycin produced significant elevation in thiobarbituric acid reactive substances (TBARS), which is an indicator of lipid peroxidation, and significantly inhibited the activity of superoxide dismutase (SOD) in heart and liver tissues, with a significant rise in the serum levels of glutamic pyruvic transaminase (GPT), glutamic oxaloacetic transaminase (GOT), creatine kinase isoenzyme (CK-MB) and lactic dehydrogenase (LDH), indicating acute cardiac toxicity. A single injection of adriamycin did not affect the cardiac or hepatic glutathione (GSH) content or cardiac catalase (CAT) activity, but hepatic CAT activity was elevated. Pretreatment with ACE inhibitors significantly reduced the TBARS concentration in both heart and liver and ameliorated the inhibition of cardiac and hepatic SOD activity. In addition, the ACE inhibitors significantly improved the serum levels of GOT, GPT, CK-MB and LDH in adriamycin-treated rats. Thus, these results suggest that captopril and enalapril possess antioxidative potential that may protect the heart against adriamycin-induced acute oxidative toxicity. This protective effect might be mediated, at least in part, by the limitation of culprit free radicals and the amelioration of oxidative stress.
Copyright 2001 John Wiley & Sons, Ltd.
Similar articles
-
Attenuation of the acute adriamycin-induced cardiac and hepatic oxidative toxicity by N-(2-mercaptopropionyl) glycine in rats.Free Radic Res. 2001 Nov;35(5):575-81. doi: 10.1080/10715760100301581. Free Radic Res. 2001. PMID: 11767415
-
Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.Eur J Pharmacol. 2008 Apr 28;584(2-3):368-75. doi: 10.1016/j.ejphar.2008.02.020. Epub 2008 Feb 19. Eur J Pharmacol. 2008. PMID: 18334254
-
Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.Pharmacol Res. 2009 Nov;60(5):373-81. doi: 10.1016/j.phrs.2009.05.007. Epub 2009 May 23. Pharmacol Res. 2009. PMID: 19467331
-
Angiotensin I converting enzyme inhibitors and the renal excretion of urate.Cardiovasc Drugs Ther. 1987;1(1):29-38. doi: 10.1007/BF02125830. Cardiovasc Drugs Ther. 1987. PMID: 3154308 Review.
-
Hepatotoxicity associated with angiotensin-converting enzyme inhibitors.Ann Pharmacother. 1993 Feb;27(2):228-31. doi: 10.1177/106002809302700220. Ann Pharmacother. 1993. PMID: 8292107 Review.
Cited by
-
Management of chemotherapy induced cardiomyopathy.Curr Cardiol Rev. 2011 Nov;7(4):245-9. doi: 10.2174/157340311799960681. Curr Cardiol Rev. 2011. PMID: 22758625 Free PMC article. Review.
-
Preventing Cardiac Damage in Patients Treated for Breast Cancer and Lymphoma: The PROACT Clinical Trial.JACC CardioOncol. 2024 Aug 27;6(5):684-696. doi: 10.1016/j.jaccao.2024.07.010. eCollection 2024 Oct. JACC CardioOncol. 2024. PMID: 39479329 Free PMC article.
-
Effects of treatment with enalapril on hepatotoxicity induced by acetaminophen in mice.Naunyn Schmiedebergs Arch Pharmacol. 2012 Sep;385(9):933-43. doi: 10.1007/s00210-012-0774-7. Epub 2012 Jul 3. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22752270
-
Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.J Am Heart Assoc. 2014 Apr 22;3(2):e000665. doi: 10.1161/JAHA.113.000665. J Am Heart Assoc. 2014. PMID: 24755151 Free PMC article. Review. No abstract available.
-
Can short-term fasting protect against doxorubicin-induced cardiotoxicity?World J Biol Chem. 2014 Aug 26;5(3):269-74. doi: 10.4331/wjbc.v5.i3.269. World J Biol Chem. 2014. PMID: 25225594 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous